Clinical trial
PsA Treatment With hOKT3γ1 (Ala-Ala)
NCT00239720 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Terminated
Key facts
| NCT number | NCT00239720 |
|---|---|
| Title | PsA Treatment With hOKT3γ1 (Ala-Ala) |
| Official title | Treatment of Psoriatic Arthritis With hOKT3γ1 (Ala-Ala) |
| Acronym | PART |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Collaborators | Immune Tolerance Network (ITN) |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Arthritis, Psoriatic |
| Intervention type | Drug |
| Interventions | hOKT3gamma1(Ala-Ala), Placebo |
| Enrollment | 4 |
| Start date | Mar 16, 2006 |
| Primary completion | Dec 1, 2006 |
| Completion | Jun 25, 2008 |
| First posted | Oct 17, 2005 |
| Last update posted | Apr 27, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: